came across this slide on Vitiligo R&D landscape... there's a lot happening in JAK inhibitor space - all of that leading to an increase in Serviceable Market for RECELL
- Forums
- ASX - By Stock
- Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt
came across this slide on Vitiligo R&D landscape... there's a...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.81 |
Change
0.130(4.85%) |
Mkt cap ! $185.6M |
Open | High | Low | Value | Volume |
$2.78 | $2.81 | $2.77 | $114.2K | 40.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 8144 | $2.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.82 | 3372 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2330 | 2.790 |
2 | 5000 | 2.780 |
1 | 3000 | 2.750 |
2 | 4839 | 2.710 |
3 | 43340 | 2.700 |
Price($) | Vol. | No. |
---|---|---|
2.800 | 76 | 1 |
2.810 | 95 | 1 |
2.820 | 3277 | 1 |
2.830 | 1670 | 2 |
2.840 | 5645 | 3 |
Last trade - 10.10am 16/08/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online